Your browser doesn't support javascript.
loading
Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3.
Haas, Michael; Kern, Christoph; Kruger, Stephan; Michl, Marlies; Modest, Dominik P; Giessen, Clemens; Schulz, Christoph; von Einem, Jobst C; Ormanns, Steffen; Laubender, Rüdiger P; Holdenrieder, Stefan; Heinemann, Volker; Boeck, Stefan.
Affiliation
  • Haas M; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377, Munich, Germany, michael.haas@med.uni-muenchen.de.
Tumour Biol ; 36(4): 2631-40, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25472579

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Serum Amyloid A Protein / Haptoglobins / Cholecalciferol / Keratin-19 / Antigens, Neoplasm Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2015 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Serum Amyloid A Protein / Haptoglobins / Cholecalciferol / Keratin-19 / Antigens, Neoplasm Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2015 Type: Article